Position in ALNY
as of Jun 30, 2026
· filed Jul 31, 2026
Position Value
$2,384,458
+$1,315,748 QoQ
Shares Held
7,921
+145.2% QoQ
Ownership
0.006%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
#310
of 784 holders
Holding Since
Jun 2024
9 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ALNY Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026J. Safra Sarasin Holding AG holds $38,071,978 across 30 Biotechnology names. ALNY ranks #3 (6.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | INSM |
INSMED Inc
|
95,602 | $10,193,085 | |
| 2 | INCY |
Incyte Corp
|
29,655 | $3,361,690 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
This page
|
7,921 | $2,384,458 | |
| 4 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
4,195 | $2,083,782 | |
| 5 | VERA |
Vera Therapeutics, Inc.
|
47,662 | $2,045,176 | |
| 6 | VRDN |
Viridian Therapeutics, Inc.\DE
|
107,839 | $1,981,002 | |
| 7 | ROIV |
Roivant Sciences Ltd.
|
49,694 | $1,758,670 | |
| 8 | RPRX |
Royalty Pharma plc
|
30,662 | $1,719,217 |
All Filings in ALNY
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,384,458 | 7,921 | Shares | Defined | 2026-07-31 | |
| 2026-03-31 | $1,068,710 | 3,230 | Shares | Defined | 2026-05-04 | |
| 2025-12-31 | $3,633,724 | 9,138 | Shares | Defined | 2026-01-15 | |
| 2025-09-30 | $4,342,032 | 9,522 | Shares | Defined | 2025-11-03 | |
| 2025-06-30 | $4,890,044 | 14,996 | Shares | Defined | 2025-07-21 | |
| 2025-03-31 | $4,437,777 | 16,435 | Shares | Defined | 2025-05-09 | |
| 2024-12-31 | $4,504,303 | 19,142 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $3,100,688 | 11,274 | Shares | Defined | 2024-11-12 | |
| 2024-06-30 | $1,669,653 | 6,871 | Shares | Defined | 2024-07-30 | |
| No filing history on record for this holder in this stock. | ||||||